X0508 4 2024-09-01 false 0001568651 Oscar Health, Inc. OSCR 0002021524 Wolin Steven 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 false true false false Chief Operating Officer false Class A Common Stock 2024-09-01 4 M false 6034.00 A 70864.00 D Class A Common Stock 2024-09-01 4 M false 2920.00 A 73784.00 D Class A Common Stock 2024-09-01 4 M false 24671.00 A 98455.00 D Class A Common Stock 2024-09-01 4 M false 1482.00 A 99937.00 D Class A Common Stock 2024-09-01 4 M false 1896.00 A 101833.00 D Class A Common Stock 2024-09-01 4 M false 1460.00 A 103293.00 D Class A Common Stock 2024-09-03 4 S false 10242.00 17.99 D 93051.00 D Class A Common Stock 2024-09-04 4 S false 5141.00 17.46 D 87910.00 D Class A Common Stock 2024-09-04 4 S false 4196.00 17.85 D 83714.00 D Restricted Stock Units 2024-09-01 4 M false 6034.00 0.00 D Class A Common Stock 6034.00 12067.00 D Restricted Stock Units 2024-09-01 4 M false 1482.00 0.00 D Class A Common Stock 1482.00 2966.00 D Restricted Stock Units 2024-09-01 4 M false 1896.00 0.00 D Class A Common Stock 1896.00 3794.00 D Restricted Stock Units 2024-09-01 4 M false 24671.00 0.00 D Class A Common Stock 24671.00 148027.00 D Restricted Stock Units 2024-09-01 4 M false 2920.00 0.00 D Class A Common Stock 2920.00 29202.00 D Restricted Stock Units 2024-09-01 4 M false 1460.00 0.00 D Class A Common Stock 1460.00 14601.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2022. The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2023. The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2024. /s/ Melissa Curtin, Attorney-in-fact 2024-09-04